ERBA Diagnostics Inc  

(Public, OTCMKTS:ERBA)   Watch this stock  
Find more results for NYSEAMEX:ERB
0.000 (0.00%)
Aug 17 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.11 - 1.10
Open     -
Vol / Avg. 0.00/14,588.00
Mkt cap 22.04M
P/E     -
Div/yield     -
EPS -0.04
Shares 44.09M
Beta 0.29
Inst. own 0%

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -9.30% 1.70%
Operating margin -7.25% 3.31%
EBITD margin - 7.34%
Return on average assets -8.83% 1.73%
Return on average equity -13.27% 2.52%
Employees 134 -
CDP Score - -


2140 N Miami Ave
MIAMI, FL 33127-4916
United States - Map
+1-305-3242300 (Phone)
+1-305-3242385 (Fax)

Website links


ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures and markets diagnostic test kits, or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology and diabetes testing. The Company's segments include Domestic and European. The domestic region contains its subsidiaries located in the United States and in Latin American and corporate operations. The European region contains its subsidiary located in Italy. Its tests are based on a range of technologies, including Enzyme Linked ImmunoSorbent Assay (ELISA) technology, clinical chemistry, hematology and cell separation, as well as high performance liquid chromatography (HPLC) separations, all of which are clinical testing methodologies used across the world. It also designs and manufactures laboratory instruments that perform the tests.

Officers and directors

Suresh H. Vazirani Executive Chairman of the Board
Age: 66
Hayden Jeffreys Interim Chief Executive Officer, Director
Age: 41
Chandra Krishnan Senior Vice President - Global Sales, Marketing and Business Development
Nikhil Vazirani Director
Gerald E. Gallwas Independent Director
Age: 79
David M. Templeton Independent Director
Age: 62